u 73343 has been researched along with 1-amino-1,3-dicarboxycyclopentane in 1 studies
| Studies (u 73343) | Trials (u 73343) | Recent Studies (post-2010) (u 73343) | Studies (1-amino-1,3-dicarboxycyclopentane) | Trials (1-amino-1,3-dicarboxycyclopentane) | Recent Studies (post-2010) (1-amino-1,3-dicarboxycyclopentane) |
|---|---|---|---|---|---|
| 97 | 0 | 6 | 893 | 0 | 17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, T; Ishii, T; Ohmori, H | 1 |
1 other study(ies) available for u 73343 and 1-amino-1,3-dicarboxycyclopentane
| Article | Year |
|---|---|
Release of Ca2+ is the crucial step for the potentiation of IPSCs in the cultured cerebellar Purkinje cells of the rat.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Calcium; Calcium Channels; Chelating Agents; Cycloleucine; Egtazic Acid; Enzyme Inhibitors; Estrenes; Evoked Potentials; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Heparin; Neuroprotective Agents; Phosphodiesterase Inhibitors; Purkinje Cells; Pyrrolidinones; Rats; Receptors, Metabotropic Glutamate; Ruthenium Red; Synapses; Thapsigargin; Type C Phospholipases | 1996 |